Ads
related to: monoclonal antibody treatment prostate cancer bone metastasis survival rate- Prostate Cancer Symptoms
Find Tips And Resources To Manage
Advanced Prostate Cancer.
- Understand Your Results
Learn About Tests And Scans Used
To Diagnose And Monitor PC.
- Support Your Loved Ones
Explore Resources And Get Guidance
On How To Care For Someone With PC.
- Patient Story Videos
Watch Real Stories Of Patients
Who Have Battled Prostate Cancer.
- Prostate Cancer Symptoms
Search results
Results from the WOW.Com Content Network
Abituzumab is a humanized IgG2 monoclonal antibody (mAb) targeted at CD51 (an integrin) currently in development by Merck KGaA Darmstadt, Germany in an attempt to prevent bone lesion metastases in castration-resistant prostate cancer. [1] [2]
Denosumab, sold under the brand names Prolia among others, is a human monoclonal antibody used for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone. [11] [12] The most common side effects are joint and muscle pain in the arms or legs. [13]
RAS (KRAS or NRAS) wild-type metastatic colorectal cancer: Skin reactions, electrolyte anomalies, anaphylaxis and angiooedema (rare). Pembrolizumab: IV: Anti-PD-1 monoclonal antibody. Melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, and stomach cancer. Fatigue, rash, itchiness (pruritus), diarrhea, nausea, joint pain (arthralgia ...
Ipilimumab, in combination with nivolumab, is indicated for the treatment of adults and adolescents twelve years and older with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer that has progressed following treatment with a fluoropyrimidine, oxaliplatin, and irinotecan.
Some examples of these complications that are a consequence of bone metastasis are: hypercalcemia, pathological fractures and spinal cord compression. [21] Some findings also suggest that some cancer cells, particularly prostate cancer cells, can activate an increase in bone remodeling and ultimately increase overall bone production. [21]
This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.
It binds to the epithelial cell adhesion molecule (EpCAM - CD326), with the intent to trigger antibody-dependent cellular cytotoxicity. It was developed by Micromet Inc, which was acquired by Amgen. [1] Adecatumumab has been used in clinical studies of treatment in colorectal, prostate [2] and breast cancers. [3] Phase II results were published ...
Anti-cancer monoclonal antibodies can be targeted against malignant cells by several mechanisms. Ramucirumab is a recombinant human monoclonal antibody and is used in the treatment of advanced malignancies. [18] In childhood lymphoma, phase I and II studies have found a positive effect of using antibody therapy. [19]
Ads
related to: monoclonal antibody treatment prostate cancer bone metastasis survival rate